Invention Grant
- Patent Title: Anti-survivin antibodies for cancer therapy
-
Application No.: US16990622Application Date: 2020-08-11
-
Publication No.: US11773181B2Publication Date: 2023-10-03
- Inventor: Robert A. Fenstermaker , Michael J. Ciesielski
- Applicant: Health Research, Inc.
- Applicant Address: US NY Buffalo
- Assignee: Health Research, Inc.
- Current Assignee: Health Research, Inc.
- Current Assignee Address: US NY Buffalo
- Agency: Hodgson Russ LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/30 ; A61K39/395 ; C07K16/18 ; C12N15/113 ; C12N15/62 ; A61K35/17 ; C12N5/16 ; C12N5/0783 ; A61K39/00
Abstract:
Provided are survivin specific antibodies, nucleic acids encoding the antibodies and methods for treating tumors comprising survivin-expressing cells by administration of the antibodies. The antibody compositions were found to be effective in inhibiting the growth of tumors.
Public/Granted literature
- US20200377613A1 ANTI-SURVIVIN ANTIBODIES FOR CANCER THERAPY Public/Granted day:2020-12-03
Information query
